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Introduction: Exclusive or associated lesions in various structures of the autonomic nervous 
system occur in the chronic forms of Chagas disease.  In the indeterminate form, the lesions 
are absent or mild, whereas in the exclusive or combined heart and digestive disease forms, 
they are often more pronounced. Depending on their severity these lesions can result mainly in 
cardiac parasympathetic dysfunction but also in sympathetic dysfunction of variable degrees. 
Despite the key autonomic effect on cardiovascular functioning, the pathophysiological and 
clinical significance of the cardiac autonomic dysfunction in Chagas disease remains unknown. 
Methods: Review of data on the cardiac autonomic dysfunction in Chagas disease and their 
potential consequences, and considerations supporting the possible relationship between this 
disturbance and general or cardiovascular clinical and functional adverse outcomes. Results: 
We hypothesise that possible consequences that cardiac dysautonomia might variably occasion 
or predispose in Chagas disease include: transient or sustained arrhythmias, sudden cardiac 
death, adverse overall and cardiovascular prognosis with enhanced morbidity and mortality, 
an inability of the cardiovascular system to adjust to functional demands and/or respond to 
internal or external stimuli by adjusting heart rate and other hemodynamic variables, and 
immunomodulatory and cognitive disturbances. Conclusions: Impaired cardiac autonomic 
modulation in Chagas disease might not be a mere epiphenomenon without significance. 
Indirect evidences point for a likely important role of this alteration as a primary predisposing 
or triggering cause or mediator favouring the development of subtle or evident secondary 
cardiovascular functional disturbances and clinical consequences, and influencing adverse 
outcomes.
Keywords: Chagas heart disease. Indeterminate form of Chagas disease. Heart autonomic 
control. Cardiac autonomic dysfunction. Cardiovascular outcomes.
RESUMO
Introdução: Lesões isoladas ou combinadas de várias estruturas do sistema nervoso autônomo 
ocorrem nas formas crônicas da doença de Chagas. Na forma indeterminada, as lesões são 
discretas e podem estar até ausentes, enquanto nas formas cardíaca e digestória exclusivas 
ou combinadas elas são comumente mais pronunciadas. Na dependência da sua maior ou 
menor severidade, estas lesões podem resultar em variáveis graus de disfunção parassimpática 
e/ou simpática, principalmente a primeira. Apesar da crítica influência autonômica sobre o 
funcionamento cardiovascular, o significado fisiopatológico e clínico, notadamente em longo 
prazo, da disfunção autonômica cardíaca permanece desconhecido na doença de Chagas. 
Métodos: Revisão sobre a disfunção autonômica cardíaca na doença de Chagas e suas 
potenciais consequências, como base para considerações acerca da possível relação entre este 
distúrbio e desfechos clínicos e funcionais globais e cardiovasculares desfavoráveis. Resultados: 
Os potenciais desfechos que a disautonomia cardíaca pode variavelmente determinar ou 
predispor na doença de Chagas incluem: arritmias transitórias ou sustentadas, morte súbita, 
mal prognóstico global e cardiovascular, morbi-mortalidade aumentada, deficiente adaptação 
cardiovascular a demandas funcionais e/ou em resposta a estímulos internos e externos 
por meio de ajustes da frequência cardíaca e outras variáveis hemodinâmicas, e distúrbios 
imunomoduladores e psico-funcionais. Conclusões: A alteração da modulação autonômica 
cardíaca na doença de Chagas pode não representar mero epifenômeno sem significado. 
Evidências indiretas sugerem papel importante desta alteração como fator predisponente ou 
determinante primário para o desenvolvimento secundário de distúrbios funcionais manifestos 
ou não e consequências clínicas cardiovasculares, e para a ocorrência de desfechos desfavoráveis.
Palavras-chaves: Cardiopatia chagásica crônica. Forma indeterminada da doença de Chagas. 
Função autonômica cardíaca. Disautonomia cardíaca. Desfechos cardiovasculares.
Insights into the clinical and functional significance of cardiac 
autonomic dysfunction in Chagas disease
Considerações sobre o significado clínico-funcional da disfunção autonômica cardíaca na 
doença de Chagas
Luiz Fernando Junqueira Junior1
The autonomic nervous system coordinates 
and modulates the harmonious and integrated 
functioning of the organism and its relations with 
the surrounding environment with fine precision.  In 
particular, the autonomic influence on the heart and 
vascular system is one of the most remarkable and 
extensive homeostatic processes in the organism. 
Therefore, disturbances to this neural regulatory 
system, even subtle or not outwardly detectable 
ones, certainly affect to some extent the homeostasis 
of the organism with both short- and long-time 
functional prejudice. In recent years, various direct 
and indirect lines of evidence have emerged linking 
lesions and disturbances of this system to various 
cardiovascular functional alterations and to higher 
mortality and morbidity in many clinical conditions.
Lesions affecting the autonomic nervous 
system linked to the heart and consequent cardiac 
dysautonomia of variable degrees are a hallmark of 
Chagas disease. These lesions have been extensively 
demonstrated both in affected subjects and 
experimental animal models. On these grounds, 
it is reasonable to assume that the autonomic 
dysfunction in Chagas disease may represent an 
example of a homeostatic disturbance acutely and 
chronically expressed in different forms and to 
variable degrees, affecting among others, neural, 
cardiovascular, endocrine, renal, immunological 
and metabolic regulatory mechanisms. In this 
context, the characterisation of the functional and 
clinical significance of chagasic cardiac autonomic 
dysfunction is a critical issue.  This aspect of the 
pathophysiology of Chagas disease is open to 
speculation, representing a question that remains to 
be fully clarified, even though more than a century 
has passed since the discovery of the disease. Several 
works have demonstrated that this disturbance result 
in significant loss of acute cardiovascular adaptation 
in response to different stimulus. On the other 
hand, virtually none observation exists showing 
that the cardiac autonomic dysfunction can result 
in important long-term cardiovascular and other 
functional consequences.
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Therefore, it seems reasonable and timely to undertake an 
insightful consideration of the possible role of the cardiac autonomic 
dysfunction in chronic Chagas disease as a possible cause or 
contributing factor of some functional disturbances and clinical 
manifestations and as a determinant of adverse outcomes.
CHAGAS DISEASE ESSENTIALS
Chagas disease is a very serious chronically debilitating and 
often fatal human endemic infectious-parasitic affection that is 
caused by the protozoan Trypanosoma cruzi and transmitted by 
hematophagous triatomid bugs. It usually victimises persons living 
in underdeveloped social and economic conditions in most South 
and Central America countries, which are endemic for the disease. A 
recently estimated cohort of about 8-10 million people living in these 
countries is chronically infected, thus carrying one of the chronic 
clinical forms of the disease. Around 50-60% of them lack evident 
manifestation and about 30-40% have obvious typical clinical and 
functional disturbances of the heart and/or digestive tract resulting in 
different, mild to severe consequences, with approximately estimated 
6-12,000 deaths per year. Nearly 28 million people are at risk of 
to acquire the disease and the number of annual new cases due to 
vectorial transmission is close to 41,0001-4. As the result of migrating 
flow, thousands of infected Latin-American immigrants are also 
living in the United States, Canada, Australia, Japan and in several 
European countries.  Indigenous cases are also present in many of 
these countries because of the geographical spreading of infected bugs 
by ecological and climatic changes. It is estimated in about 400,000 
the number of infected subjects in these non-endemic countries5,6.
A myriad of unique and intriguing pathological, patho-
physiological and clinical aspects regarding the heart and digestive 
tract are markers of Chagas disease. This disease manifests under 
an acute form, which is followed, usually after some decades, by 
one of the different chronic forms. The acute form often shows 
infectious nonspecific symptoms for a few days, or it may proceed 
to eventual myocarditis of variable severity. In the chronic form 
named indeterminate form, the diagnosis is based only on positive, 
specific serological tests. Most of the affected subjects remain in 
this form for their lifetime having excellent long-term prognoses, 
while showing clinical and functional normality as characterised 
at the primary diagnostic level by clinical examination, standard 
electrocardiogram (ECG) and X-rays (Rx) of the heart and digestive 
tract. However, some chagasics with this form show subtle cardiac 
functional disturbances detectable by more sophisticated and 
sensitive exams, such as Doppler echocardiography, 24h ECG, 
electrophysiological studies and autonomic tests1,4,7-10.
The other chronic forms, which may evolve or not from the 
indeterminate form, are the cardiac form, the digestive form, and 
the cardiac plus digestive associated form, expressing the exclusive 
or associate involvement of the heart and digestive tract. In these 
forms, the underlying pathological changes determining the clinical 
and functional manifestations are inflammatory and degenerative 
lesions and fibrosis of the affected structures, which occur with 
variable intensity and extension and progress gradually from an 
acute to a chronic pattern. In the heart, the structures exclusively 
or associatively affected are mainly the atrial and ventricular 
myocardium, the specialised electrical excitation and conduction 
tissue, the intrinsic neural network, the postganglionic autonomic 
innervation and neurotransmitter cellular receptors, and the coronary 
microcirculation11-15.
During its course, the disease may show various specific clinical 
and/or functional manifestations with or without symptoms of 
variable severity and occurring exclusively or in association. These 
manifestations include systolic and/or diastolic dysfunction, heart 
enlargement with or without failure, a great variety of hypokinetic 
and hyperkinetic arrhythmias and other electrophysiological 
disturbances, cerebral or pulmonary thromboembolism, digestive 
megasyndromes, cardiac autonomic dysfunction and expected or 
unexpected sudden cardiac death. The form involving the heart 
shows high morbidity and mortality with considerable potential 
for short- and middle-term disability and poor prognosis in about 
30-40% of affected subjects. At the primary level, the diagnosis 
of cardiac and digestive forms depends on finding alterations in a 
standard electrocardiogram and radiological signs of enlargement 
of the digestive tract segments, respectively, independently of the 
presence of clinical symptoms and signs, but in the presence of 
positive serology for the disease1,2,4,10,11,16,17-19.
CARDIAC AUTONOMIC NERVOUS SYSTEM IN 
CHAGAS DISEASE
Diffuse damage to the autonomic nervous system, principally 
of the parasympathetic branch affecting the heart and digestive 
tract, is a remarkable pathological feature commonly present in 
variable degrees and extents in the acute and all chronic forms 
of human Chagas disease11,13,15,17-19 and the corresponding forms 
of experimental Trypanosoma cruzi infection in different  animal 
models20-24. This is a fact recognised soon after the description of 
the disease at the beginning of the past century. Autonomic damage 
expressed by neuronal and ganglionic inflammation and destruction 
with variable loss of nerve cells is credited to initiate in the acute 
phase and continue into the chronic phase, occurring through non-
immune or parasitic and immune mechanisms acting exclusively or 
in combination11,15,25.
Many autonomic components, mainly related to functional 
modulation of the heart and digestive viscera, including central 
neural structures at different levels, peripheral extrinsic and intrinsic 
autonomic ganglia, afferent neurons from receptors, sympathetic 
and parasympathetic efferent neurons and the beta-adrenergic and 
muscarinic cholinergic neurotransmitter cellular receptors, may be 
injured exclusively or in combination, and this has been demonstrated 
both in human and experimental Chagas disease11,13,15,18,20-23,26-29. 
Several studies have shown less pronounced lesions of the 
cardiac parasympathetic innervation in the indeterminate form, 
which are usually represented by discreet to moderate focal or 
zonal neuroganglionitis. In the isolated or associate cardiac and 
digestive forms of the disease, the intrinsic innervation of the heart 
is often more severely damaged by inflammatory and degenerative 
alterations. Moreover, a decrease in the number of cardiac ganglion 
cells and neurons has clearly been shown, and both parasympathetic 
and sympathetic lesions have been described11,13,15,18,21-24,28,30.
As expected from these pathological features, a particular 
functional disturbance in the different forms of Chagas disease is a 
variable impairment of the autonomic modulation of the involved 
organs, especially the heart and digestive tract. In the heart, the 
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autonomic dysfunction may to affect, exclusively or in combination, 
the electrical properties of the sinus and atrioventricular node and 
the intraventricular conducting system, as well as the electrical and 
mechanical properties of the atrial and ventricular myocardium. 
Classical autonomic tests and heart rate variability analysis have 
evaluated impairment of autonomic control exclusively on the 
sinus node. They have demonstrated that cardiac parasympathetic 
and/or sympathetic dysfunctions are present in many affected 
subject, being both observed not only in chagasics with exclusive 
or combined evident cardiomyopathy but also in those with the 
exclusive digestive form or without overt manifestations of heart or 
digestive damage. Normal autonomic modulation of the heart is also 
encountered in chagasics with any form of the disease. When present, 
the disturbance occurs with variable severity according to the chronic 
form of the disease and even between subjects affected with the same 
form8,9,17,30-37. Chronically infected children with the indeterminate 
form also show cardiac autonomic dysfunction38. Chagasics with 
arterial hypertension also present impaired cardiac parasympathetic 
modulation, apparently to the same extension as chagasics without 
hypertension39. However, a sample of elderly chagasics with the 
indeterminate form of the disease did not showed any alterations 
in cardiac autonomic function as compared with healthy elderly 
subjects40. Contrasting with this finding, elderly chagasics below 
70 years, but not those older, with an uncharacterised form of the 
disease, show reduced vagal modulation41. 
It seems that the intensity of the cardiac autonomic functional 
disturbance is strictly correlated with the clinical form of chagasic 
organic involvement. Usually, mild autonomic dysfunction occurs 
in the indeterminate form and in chagasics showing a borderline 
electrocardiogram, the severe disturbances occur in the cardiac-
digestive and digestive forms, and moderate dysfunction occurs in 
the exclusive cardiac form8,10,32,33.
In addition to the lesions in different structures of the autonomic 
nervous system, exclusive degenerative and inflammatory damage in 
effectors of the autonomic influence on the heart, such as the sinus 
and atrioventricular nodes and the bundle of His may also occur 
with resultant secondary cardiac autonomic dysfunction42. Similarly, 
lesions in the myocardium may also result in disturbed autonomic 
modulation of atrial and ventricular electrical and mechanical 
properties. Cardiac and vascular mechanoreceptors, central and 
peripheral chemoreceptors and afferent neural fibres in the heart and 
lungs seem also to be damaged, which may impair cardiopulmonary 
baroreflexes and modify chemoreflex responses43,44.
The diagram in Figure 1  shows proven and possible 
pathophysiological mechanisms of the cardiac autonomic 
dysfunction triggered by Trypanosoma cruzi infection, which may 
culminate in different clinical and functional manifestations.
Despite the extensively recognised and well-established 














































FIGURE 1 - Trypanosoma cruzi may affect, in combination or exclusively, all of the structures of the heart by means of toxicity or 
inflammatory effects, resulting in lesions that affect both the intrinsic autonomic innervation, the exciting-conducting system 
and the contractile myocardial fibres.
One of the important consequences is cardiac autonomic dysfunction, which has been repeatedly demonstrated to be a primary disturbance 
independent of contractile dysfunction. This impaired autonomic function may be the substrate for various secondary functional and clinical 
manifestations. The continuous lines show proven pathophysiological relationships, and the dotted lines show possible but unproven 
disturbances. 
SN: sinus node; AVN: atrioventricular node; BH: bundle of His.
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and clinical significance of the cardiac autonomic dysfunction 
remains one of the major challenges to overcome in Chagas disease 
research. No study has yet fully considered the short- and long-term 
prognostic significance, functional cardiovascular limitations and 
potential risks for adverse outcomes associated with the cardiac 
autonomic dysfunction, and many questions remain unanswered16. 
Is the cardiac autonomic dysfunction in Chagas disease a simple 
epiphenomenon without any functional, clinical or prognostic 
significance? Does it constitute a key physiopathogenetic link or 
triggering cause for the development of secondary disturbances 
and manifestations such as different arrhythmias, sudden death, and 
continuing contractile failure? Could it represent a risk factor for 
cardiovascular or general morbidity and mortality? Or, alternatively, 
is it an underlying mechanism for altered homeostasis imposing 
inappropriate short- and long-term cardiovascular adaptation to 
multiple internal or external stressful stimuli?
The role of cardiac autonomic dysfunction in determining these 
outcomes in Chagas disease probably is not a mere guess, but a 
real possibility, as we first hypothesised, considering the important 
influence of the autonomic nervous system on all the electrical and 
mechanical properties of the heart and on cardiovascular and general 
morbidity and mortality16,28,45,46. Also, several recent observations 
have emerged linking unfavourable cardiovascular outcomes to 
cardiac dysautonomia in various pathological conditions that affect 







































FIGURE 2 - Sympathetic and parasympathetic impairments of variable degree may affect all the properties and functional 
mechanisms of the heart, resulting in electrical, mechanical, coronary and, possibly, endocrine dysfunctions.
Figure 2 depicts possible clinical and functional disturbances 
likely to result or be influenced by impaired autonomic modulation 
on the different structures and functional properties of the heart.
AUTONOMIC AND CONTRACTILE  
DYSFUNCTION 
Regarding the possible relationship between ventricular and 
autonomic dysfunctions, it was originally proposed that cardiac 
autonomic denervation would be the direct and primary cause 
of the myocardial contractile deficiency and the advancement of 
this mechanical disturbance until the phase of congestive heart 
failure. This is the neurogenic theory of the physiopathogenesis of 
chronic Chagas heart disease, by which this condition would be a 
neurocardiopathy consequent to parasympathetic impairment, and 
therefore unbalanced sympathetic dominance would submit the 
heart to excessive adrenergic activity with resultant increasing organ 
deterioration and failure11.
However, a great number of subsequent pathological, functional 
and clinical studies have formed a widely accepted physiopathogenetic 
concept according to which cardiac autonomic denervation and the 
resultant functional disturbances are not the determining mechanism 
neither of the progressive cardiomegaly of Chagas disease nor the 
ensuing heart failure in the most cases. The progressive contractile 
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As a consequence, distinctive functional and clinical disturbances or manifestations may occur, thereby conferring to the autonomic impairment 
potentially important pathophysiological and prognostic significance in Chagas disease. The solid lines show established mechanisms and the 
dashed lines show possible mechanisms underlying different cardiac pathological conditions. 
HR: heart rate; BP: blood pressure; CO: cardiac output; PR: peripheral resistance. 
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dysfunction of the heart critically depends on the underlying 
evolutionary chronic fibrotic inflammation of the myocardium15,17,54. 
Therefore, the autonomic denervation and the consequent 
disturbance of neural heart control do not seem to be a direct cause 
of the contractile dysfunction19,34,37,55,56.
On the other hand, several lines of evidence have clearly 
proven that the progressive contractile mechanical disturbance 
does not result in secondary autonomic dysfunction, except in the 
phase of heart failure where this functional disturbance is present 
in variable degree. These evidences include the demonstration 
that contractile alteration of the right ventricle is independent of 
autonomic dysfunction34, parasympathetic impairment precedes 
the left ventricular systolic dysfunction35, and that chronotropic 
incompetence in response to exercise testing is an early warning of 
cardiac autonomic disturbance that is independent of ventricular 
function57. In addition, we observed pronounced sympathetic and 
parasympathetic depression with preserved sympathovagal balance 
as evaluated by short-term heart rate variability, which occurred 
with virtually unaltered morphological and functional ventricular 
echocardiographic parameters. The unique ventricular alteration was 
an increased left ventricular end systolic diameter, and this was directly 
associated with cardiac autonomic impairment. This marked imbalance 
between autonomic and ventricular dysfunction reinforces that there 
is no precise causal relationship between the two and that autonomic 
impairment may precede ventricular alterations in this disease37. 
Therefore, all of these results suggest that cardiac autonomic 
impairment is a primary phenomenon, being neither a cause nor 
the result of the continuing chronic contractile dysfunction in 
Chagas heart disease.  Despite this, it is not possible to eliminate 
the possibility that autonomic and contractile dysfunction mutually 
influence or worsen one another to some extension37,58. However, 
an isolated alternative hypothesis considers that cardiac autonomic 
dysfunction is the result of contractile ventricular dysfunction and 
other primary pathophysiological mechanisms59.
DYSAUTONOMIC ARRHYTHMOGENESIS 
 - A WORKING HYPOTHESIS
Based on the previous considerations, an expected attractive and 
logical implication of cardiac autonomic dysfunction as a determining 
or predisposing pathophysiological risk factor, perhaps one of higher 
relevance and clinical consequence, concerns the physiopathogenesis 
of arrhythmias and even sudden cardiac death16, which are so 
common in Chagas heart disease1,28,45,60,61.
Indeed, the autonomic nervous system critically modulates all of 
the electrophysiological properties of the electrical and contractile 
tissues of heart (automatism, conductibility and excitability) 
whose alterations are the underlying causes of arrhythmogenesis. 
The parasympathetic branch exerts depressive or stabilising 
anti-arrhythmogenic electrophysiological effects and a negative 
inotropism, while the sympathetic branch has a pro-arrhythmogenic 
stimulatory effect and exerts a positive inotropism; an adequate 
balance between these autonomic influences on the heart is essential 
for maintaining the electrical stability of the myocardium and the 
excitation and conducting system. Therefore, parasympathetic 
depression or sympathetic overactivity could increase the 
vulnerability to arrhythmogenesis. Consequently, changes of variable 
degree affecting the sympathetic-parasympathetic balance on the 
heart in favour of absolute or relative sympathetic dominance may 
result in electrophysiological instability and induce arrhythmias of 
different types with a broad severity spectrum. 
Changes in autonomic modulation can be triggered or 
exacerbated by different intrinsic or extrinsic factors involving the 
heart-brain relationship, such as primary neural and cardiac factors 
and a great sort of emotional, psychosocial and stressors factors. 
The arrhythmias can to generate even sudden death depending on 
the extent and speed of onset of such neurocardiac alterations and 
on the pathological and functional substrate of the myocardium 
and excitation and conducting tissues.  It is possible that even 
physiological changes of the cardiac autonomic system acting on a 
damaged heart substrate are able to produce arrhythmias. Figure 3 
depicts these final common potential physiopathological mechanisms 
of arrhythmogenesis that can be provoked by sympathetic and/or 
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FIGURE 3 - Potential pathophysiological pathways of autonomic 
arrhythmogenesis. Relative or absolute physiological or pathological changes 
in sympathetic and/or parasympathetic activity of the healthy or vulnerable 
heart may induce alterations in cardiac electrical properties potentially able to 
result in arrhythmias of variable severity and even sudden death.
In Chagas heart disease, isolated or combined lesions of 
variable magnitude and extent affecting the atrial and ventricular 
myocardium, the specialised excitation and conducting system and 
the intrinsic autonomic innervation of the heart especially propitiate 
the development of arrhythmias of different types, severity and 
duration, from which may arise life-threatening events resulting 
in unexpected or expected sudden death. Distinctive patterns of 
autonomic disturbances, associated or not with myocardial and 
specialised tissue lesions, are critically important considering their 
potential to cause or worsen changes in all the electrophysiological 
properties of heart, eventually triggering some kind of arrhythmia. 
Hypothetically, the more discrete the autonomic dysfunction 
with subtle sympathetic-parasympathetic imbalances resulting from 
focal or zonal intrinsic neuroganglionic lesions, the higher is the 
vulnerability to arrhythmogenesis and the potential for unexpected 
sudden death, as commonly occurs in chagasic subjects with heart 
disease of mild to moderate severity and perhaps occasionally in those 
with the indeterminate form or a borderline electrocardiogram1,16,60,61. 
On the other hand, more pronounced autonomic impairment 
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resulting from marked and extensive lesions at different levels of 
the intrinsic nervous system may associate with a reduced chance 
of arrhythmogenesis and sudden death. Therefore, chagasics with 
relatively severe cardiac intrinsic autonomic denervation may be 
protected against the phenomenon of arrhythmogenesis, considering 
that in such cases the heart is practically disconnected from the 
extrinsic nervous system and is free of unbalanced autonomic 
influences on its electrophysiological properties resulting from 
internal or external stimuli16.
Some observations support the proposed hypothesis of 
dysautonomic arrhythmogenesis in Chagas disease. Studies from 
hearts with myocardial infarction and other lesions have raised the 
possibility that heterogeneous axonal regeneration and proliferation 
of sympathetic nerves following the damage may cause electrical 
heterogeneity and instability with consequent arrhythmias as a result 
of regional hyperinnervation or nerve sprouting62,63. The coexistence 
of denervated and hyperinnervated area in the damaged myocardium 
could result in increased electrophysiological heterogeneity during 
absolute or relative sympathetic overactivity of diverse origin leading 
to ventricular hyperkinetic arrhythmias63.  
In this context, it is reasonable to hypothesise that in Chagas 
disease, the same pathophysiological mechanism may trigger 
arrhythmogenesis, considering the regional heterogeneity of 
the lesions in the intrinsic innervation11,13,22,30 and in ventricular 
myocardium64 of the chagasic heart. Indeed, an association 
between regional myocardial sympathetic denervation, detected 
by scintigraphy with123I-metaiodobenzylguanidine, and the 
occurrence of sustained ventricular tachycardia was observed in 
chagasic cardiomyopathy with preserved ventricular function64, and 
sympathetic modulation was noted to be affected in the ventricular 
myocardial also in chagasic subjects with the indeterminate form 
or borderline electrocardiogram65. In addition, cardiac sympathetic 
and cholinergic reinnervation was showed at least in experimental 
Chagas disease, and is likely that these phenomena occur in a 
regional heterogeneous manner resulting in unbalanced autonomic 
effect as a potential arrhythmogenic mechanism66,67. A finding of 
myocardial lesions similar to those induced by catecholaminogenic 
cardiotoxicity, which can represent a substrate for the induction of 
arrhythmias, in chagasic subjects without clinical manifestations 
who died suddenly and unexpectedly45, reinforces the hypothesis 
of dysautonomic arrhythmogenesis as a possible cause of sudden 
death in Chagas disease16.
In addition, observations of impaired cardiac autonomic 
modulation on the sinus node as detected by conventional linear or 
nonlinear heart rate variability analysis in subjects with Chagas heart 
disease have also stressed the possibility of a link between autonomic 
dysfunction and arrhythmias46,68. Moreover, several studies based on 
heart rate variability analysis in patients with coronary disease have 
showed that altered autonomic influence on the heart has a key role 
in the vulnerability, development and maintenance of life-threatening 
arrhythmias, which may result in sudden death49,50,69. A shift of the 
sympatho-vagal balance toward sympathetic dominance has been 
demonstrated before the beginning of arrhythmic events such as 
ventricular tachycardia and fibrillation50,62. Reduced complexity of 
heart rate variability as assessed by nonlinear dynamic analysis has 
also been noted before the initiation of ventricular tachyarrhythmias 
in patients with Chagas heart disease, suggesting impaired cardiac 
autonomic control as the underlying mechanism46. In Brugada 
syndrome, subjects with autonomic dysfunction show syncope, 
aborted sudden death and arrhythmias more often than those without 
the disturbance53. 
Nevertheless, one study in a cohort of Chagas heart disease 
subjects observed no prognostic prediction of a time-domain index 
of heart rate variability (SDNN-standard deviation of normal-to-
normal heart intervals)70. However, this was the sole index evaluated 
in this study and was derived from series of ECG R-R intervals 
employing the 24h Holter monitoring, which methodologically 
show some restrictions limiting the heart rate variability analysis and 
interpretation. To this regard, it should be reinforced that there are 
abundant data supporting the prognostic significance and the role as 
risk marker of some classical linear and newer non-linear measures 
of heart variability in different clinical conditions other than Chagas 
disease48-52,69,71. But, several factors influence the prognostic value 
of heart rate variability measurements when they are used in risk 
stratification, which among the more important are: a) the type and 
combination of indexes, b) the nature of the autonomic modulation 
that the indexes reflect, if overall or parasympathetic or sympathetic 
exclusive or balanced one, c) the circadian rhythm of heart rate 
variability, d) the epoch of evaluation  during the development of 
the clinical, functional or pathological condition analysed, e) the 
severity of left ventricular dysfunction, f) the method employed to 
achieve, process and editing the ECG R-R intervals series, if derived 
from 5min short-term recording in controlled experimental setting, 
or long-term ambulatory 24h Holter recording under uncontrolled 
interfering factors and non-stationary data series, g) the nature of 
the selected adverse outcome50,51,69,71.
DISTURBED CARDIOVASCULAR HOMEOSTATIC 
NEURAL REGULATION 
In diseases where the autonomic nervous system is involved, an 
important expected pathophysiologically and clinically significant 
effect of autonomic impairment may be inadequate short-term or 
long-term cardiovascular adaptation to different stimuli or functional 
conditions. This functional failure may be the result of compromised 
electrophysiological and mechanical tonic and reflex responses of 
the heart, which mainly affect heart rate, blood pressure, peripheral 
resistance, venous return and cardiac output.  Underlying this 
adaptive inability is a relative or absolute impairment of sympathetic 
and parasympathetic cardiac modulation, which results in reduced 
homeostatic capacity and vulnerability to functional disturbances or 
detrimental effects of certain internal and external stimuli.
In Chagas disease subjects without heart failure, poor 
cardiovascular adjustment has been observed in steady-state and in 
connection with different transient functional conditions as result 
of altered reflex mechanisms.  Deficient chronotropic responses 
have been noted during both dynamic57,72 and isometric73 exercise 
in chagasics with heart disease. The inability to achieve adequate 
tachycardia and blood pressure stabilisation upon standing has 
also been demonstrated74-76. Depressed sensitivity of the baroreflex 
mechanism resulting in blunted bradycardia or tachycardia in 
response to acute elevation or reduction of arterial pressure has 
been observed32,77, as have altered baroreflex responses traduced by 
deficient heart rate responses during and after the Valsalva manoeuvre 
in chagasics with any form of the disease8,33,36,78,79. Additionally, 
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moment-to-moment heart rate variability is variably depressed in 
chagasic subjects both in supine and standing positions9,10,39,41,46,68,80. 
These autonomic cardiovascular disturbances occur most often in 
chagasics with exclusive or combined heart disease. Therefore, in 
people with Chagas disease, deficiencies in short- and long-term 
autonomic adjustments of hemodynamic variables in response 
to different functional demands or to stressful physiological or 
psychological stimuli might affect the efficiency and accuracy of 
moment-to-moment cardiovascular adaptation. These individuals 
may be unable to adequately perform their physical and physiological 
activities, they may reveal subtle or evident manifestations of poor 
cardiovascular health, and they may still exhibit the substrate for 
continuous development of cardiovascular disturbances16. In fact, 
several observations suggest that alterations of autonomic regulatory 
physiological processes or influences responsible for cardiovascular 
adaptation dynamics may be a mechanism for the development of 
functional derangements and disease states81-83.
Finally, recent findings have shown a positive correlation between 
reduced heart rate variability caused by autonomic impairment and 
poor prognosis represented by increased morbidity and mortality in 
coronary disease, diabetes mellitus, heart failure and non-coronary 
sudden death; that is, the more heart rate variability is depressed, 
the worse the outcome48-52,69,84. In this context, it is likewise possible 
that the loss of homeostatic adaptive capacity dependent on 
changes in heart rate consequent to permanently impaired cardiac 
autonomic modulation capacity in Chagas disease may contribute 
to its progression and to increase of the cardiovascular and overall 
mortality and morbidity of affected subjects.
OTHER POSSIBLE EFFECTS OF AUTONOMIC 
DYSFUNCTION
Besides the cardiac involvement, systemic autonomic lesions 
also occur in Chagas disease11 and may affect metabolic, renal and 
endocrine mechanisms and certain homeostatic controls. Moreover, 
considering the intricate relationship between different organ 
systems and processes, the proper cardiac autonomic dysfunction is 
expected to be correlated with metabolic, hormonal and functional 
renal disturbances. Indeed, cardiac autonomic dysfunction has 
been observed in chagasic subjects with either indeterminate or 
cardiac forms of the disease and in experimentally Trypanosoma 
cruzi-infected animals simultaneously with altered osmoregulation 
dependent on the antidiuretic hormone response85, altered 
hydroelectrolytic balance86 and altered glucose tolerance87.
Another possible pathophysiological role of chagasic autonomic 
dysfunction, irrespective of the organ involved, concerns the 
induction of immunomodulatory disturbances and alterations of 
immunological mechanisms participating in the defence against the 
parasite responsible for the disease25. Recent evidence shows that 
the autonomic nervous system significantly modulates processes 
implicated in cellular and humoral immunity as a consequence of 
the close anatomical and functional relationship between this system 
and the immune system88. This finding raises the possibility that the 
autonomic dysfunction associated with chagasic infection could be 
an influential or determining cause of immunological alterations 
contributing to the development and maintenance of chronic Chagas 
chronic infection. In this regard, an association between cardiac 
autonomic dysfunction and altered levels of cytokines was recently 
demonstrated in chagasics with the indeterminate and cardiac forms 
and with sustained parasitemia; the heart disease patients showed 
higher concentrations of IL-10 and lower IFN-γ, suggesting some 
disturbance of the process of immune regulation89.
Difficulty in coping with social stress and in controlling emotions 
can also occur in subjects with systemic autonomic impairment or 
even in just cardiac autonomic impairment, because the integrity of 
parasympathetic homeostatic function is important for the adequate 
performance of these tasks, and the heart is crucial to providing 
functional adaptation for them82,83,90. Therefore, chagasic subjects 
may also be susceptible to psycho-functional derangements attendant 
on functional demands for higher cerebral processes in association 
with their autonomic cardiovascular adaptive disability, as suggested 
by some evidences91,92. In fact, at least in other clinical conditions 
as the Alzheimer’s disease, cognitive status and cardiac autonomic 
modulation evaluated by heart rate variability appear to be correlated 
in the sense that people with lower cardiac parasympathetic 
modulation and tendency for higher sympathetic modulation show 
more severe cognitive deficiencies93.
IMPLICATIONS FOR TREATMENT
If some functional and clinical manifestations of Chagas disease 
can be shown to be related in some extent to cardiac autonomic 
impairment, a perspective based on treatment of this disturbance 
emerges for the control or prevention of these manifestations and 
expectative of improving outcomes and more favourable long-term 
prognostic. At present, no effective treatment exists for chagasic 
cardiac autonomic dysfunction and some kind of therapy has rarely 
been evaluated.
In one study, re-establishing of altered blood pressure and heart 
rate responses to various autonomic tests, reduction of arrhythmias 
and other beneficial effects were observed after administering 
Cronassial, a mixture of neuroregenerator gangliosides94,95. This 
agent, however, showed questionable security and has not been 
employed. Stem-cell therapy is a potential means of repairing injured 
cardiac autonomic intrinsic innervation96, but it has not yet proven 
to be effective and practical, and their effectiveness and application 
has actually an uncertain expectative. 
Use of beta-blockers and other drugs that directly affect 
autonomic modulation by increasing parasympathetic activity and/
or reducing sympathetic activity is a logical and reasonable alternative 
to be investigated.  In this context, it is possible that beneficial effects 
of beta-blockers on the hemodynamic status, outcomes and mortality 
of chagasic patients with heart failure97 be at least in part to the 
improvement of cardiac autonomic modulation.  With respect to 
the alpha-beta-blocker drug carvedilol, one study in our laboratory 
demonstrated that when this drug was administered to subjects 
with heart failure due to Chagas disease98 or other aetiologies99, 
improvement of depressed cardiac autonomic modulation was 
observed, as evidenced by enhanced heart rate variability associate 
with better hemodynamic and clinical status.  In other study in 
chagasics with cardiomyopathy and heart failure, the same functional 
cardiac and clinical benefits were observed after addition of carvedilol 
to conventional theray100. Therefore, knowledge about the cardiac 
autonomic dysfunction in Chagas disease has implications that reach 
far beyond its functional and clinical significance.
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CONCLUDING REMARKS AND PERSPECTIVES
In spite of the significant advances achieved in more than 
one century of research since the discovery of the disease, the 
functional and clinical implications of the cardiac autonomic 
impairment in Chagas disease are incompletely understood and can 
only be conjectured. There are few substantial direct pathological, 
pathophysiological, clinical or epidemiological findings linking 
variable degrees of cardiac autonomic dysfunction with any other 
disturbance or clinical manifestation of Chagas disease, although 
the real likelihood of such a relationship. However, several indirect 
lines of evidence point to a likely important role of the cardiac 
autonomic dysfunction as a primary trigger or mediator favouring the 
development of various cardiovascular functional disturbances and 
the emergence of certain clinical consequences, thereby influencing 
cardiovascular outcomes and mortality.
The possible effects that evident or subtle cardiac autonomic 
dysfunction might variably provoke in subjects affected by Chagas 
disease include transient arrhythmic events or sustained arrhythmias, 
sudden cardiac death, adverse general and cardiovascular prognosis, 
and incompetence of cardiovascular system to adequately adapt via 
quick and moment-to-moment heart rate variations and changes 
in other hemodynamic variables to meet functional demands 
or to respond to internal or external stimuli. The hypothesis of 
dysautonomic arrhythmogenesis is proposed on the basis of an 
unbalanced sympathetic and parasympathetic autonomic activity 
or heterogeneous influence of one and other acting on an injured 
myocardial and/or excitation and conducting tissue. Although these 
consequences are straightforward and expected for chagasics with 
heart disease of any severity, for those with the indeterminate form, 
the validity of these effects is a more difficult question considering 
the discreteness of the cardiac autonomic impairment when present 
and the good long-term prognosis of this form of the disease1,7-10.
Impaired autonomic modulation of the heart in Chagas disease 
might not be a mere epiphenomenon without significance, and 
it is intuitive and reasonable to assume that it can be a somewhat 
important primary predisposing or triggering cause or marker of 
different, subtle or evident secondary functional disturbances and 
clinical manifestations. Well-controlled transverse and longitudinal 
studies are expected to be undertaken focusing on elucidating 
the pathophysiology, clinical manifestations and significance of 
chagasic cardiac autonomic dysfunction, especially concerning 
arrhythmogenesis, sudden death and continuing contractile 
deterioration. Another important line of research is evaluating the 
extent to which disrupted cardiovascular adaptive homeostasis 
deriving from autonomic impairment is a risk factor for general 
morbidity and mortality and adverse clinical outcome in the different 
forms of Chagas disease.
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